These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23037875)

  • 1. Late administration of surfactant replacement therapy increases surfactant protein-B content: a randomized pilot study.
    Keller RL; Merrill JD; Black DM; Steinhorn RH; Eichenwald EC; Durand DJ; Ryan RM; Truog WE; Courtney SE; Ballard PL; Ballard RA
    Pediatr Res; 2012 Dec; 72(6):613-9. PubMed ID: 23037875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot trial of late booster doses of surfactant for ventilated premature infants.
    Merrill JD; Ballard PL; Courtney SE; Durand DJ; Hamvas A; Hibbs AM; Lu KW; Ryan RM; Reynolds AM; Spence K; Steinhorn RH; Truog WE; Eichenwald EC; Ballard RA
    J Perinatol; 2011 Sep; 31(9):599-606. PubMed ID: 21311500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant status and respiratory outcome in premature infants receiving late surfactant treatment.
    Ballard PL; Keller RL; Truog WE; Chapin C; Horneman H; Segal MR; Ballard RA;
    Pediatr Res; 2019 Feb; 85(3):305-311. PubMed ID: 30140069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunction of pulmonary surfactant in chronically ventilated premature infants.
    Merrill JD; Ballard RA; Cnaan A; Hibbs AM; Godinez RI; Godinez MH; Truog WE; Ballard PL
    Pediatr Res; 2004 Dec; 56(6):918-26. PubMed ID: 15496605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide.
    Ballard RA; Keller RL; Black DM; Ballard PL; Merrill JD; Eichenwald EC; Truog WE; Mammel MC; Steinhorn RH; Rogers EE; Ryan RM; Durand DJ; Asselin JM; Bendel CM; Bendel-Stenzel EM; Courtney SE; Dhanireddy R; Hudak ML; Koch FR; Mayock DE; McKay VJ; O'Shea TM; Porta NF; Wadhawan R; Palermo L;
    J Pediatr; 2016 Jan; 168():23-29.e4. PubMed ID: 26500107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface film formation in vitro by infant and therapeutic surfactants: role of surfactant protein B.
    Danhaive O; Chapin C; Horneman H; Cogo PE; Ballard PL
    Pediatr Res; 2015 Feb; 77(2):340-6. PubMed ID: 25360829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choosing a right surfactant for respiratory distress syndrome treatment.
    Ramanathan R
    Neonatology; 2009; 95(1):1-5. PubMed ID: 18832858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age.
    Keller RL; Eichenwald EC; Hibbs AM; Rogers EE; Wai KC; Black DM; Ballard PL; Asselin JM; Truog WE; Merrill JD; Mammel MC; Steinhorn RH; Ryan RM; Durand DJ; Bendel CM; Bendel-Stenzel EM; Courtney SE; Dhanireddy R; Hudak ML; Koch FR; Mayock DE; McKay VJ; Helderman J; Porta NF; Wadhawan R; Palermo L; Ballard RA;
    J Pediatr; 2017 Apr; 183():19-25.e2. PubMed ID: 28100402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory Mediators in Tracheal Aspirates of Preterm Infants Participating in a Randomized Trial of Inhaled Nitric Oxide.
    Laube M; Amann E; Uhlig U; Yang Y; Fuchs HW; Zemlin M; Mercier JC; Maier RF; Hummler HD; Uhlig S; Thome UH
    PLoS One; 2017; 12(1):e0169352. PubMed ID: 28046032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant composition and function in a primate model of infant chronic lung disease: effects of inhaled nitric oxide.
    Ballard PL; Gonzales LW; Godinez RI; Godinez MH; Savani RC; McCurnin DC; Gibson LL; Yoder BA; Kerecman JD; Grubb PH; Shaul PW
    Pediatr Res; 2006 Jan; 59(1):157-62. PubMed ID: 16326985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
    Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A
    Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchoalveolar lavage surfactant protein a, B, and d concentrations in preterm infants ventilated for respiratory distress syndrome receiving natural and synthetic surfactants.
    Beresford MW; Shaw NJ
    Pediatr Res; 2003 Apr; 53(4):663-70. PubMed ID: 12612206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
    Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
    Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled nitric oxide for respiratory failure in preterm infants.
    Barrington KJ; Finer NN
    Cochrane Database Syst Rev; 2007 Jul; (3):CD000509. PubMed ID: 17636641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.